Although decreased C4 levels have been occasionally reported in some patients (23, 48), its significance remains unclear probably due to the lack of evidence in the activation of classical and/or lectin pathways in STEC-HUS (9, 14, 22, 49). The gene discussed is C4A; the disease is hemolytic-uremic syndrome.